Takeda Pharmaceutical Company Limited (TAK) Reports Q2 EPS of JPY151.00

Takeda Pharmaceutical Company Limited (NYSE: TAK) reported Q2 EPS of JPY151.00. Revenue for the quarter came in at JPY1106.7 billion.

For earnings history and earnings-related data on Takeda Pharmaceutical Company Limited (TAK) click here.

You May Also Be Interested In

• Takeda names Julie Kim as president and CEO after shareholder vote
• Alimentation Couche-Tard Inc (ATD/B:CN) (ANCUF) PT Raised to Cdn$104 at UBS
• JPMorgan Downgrades HCL Technologies (HCLT:IN) to Underweight